Is stem cell therapy for Stroke Recovery FDA-approved?
The FDA consumer alert states that the promoted stem-cell and exosome products it addresses are not approved to treat stroke. Approval of a rehabilitation device or acute stroke medicine does not validate a cell product.
How stem cells are studied for Stroke Recovery
Stroke causes focal brain injury from blocked blood flow or bleeding. Cell research explores immune modulation, trophic support and neural repair, but intravenous MSCs, neural progenitors, exosomes and intracerebral products are different interventions. None should be described as replacing lost brain tissue or guaranteeing restored movement, speech or cognition.
Am I a candidate? → · Stroke Recovery: full overview → · Stroke Recovery cost → · Cost →
Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.
Sources & further reading
More on this condition
- Stroke Recovery: cell-therapy evidence and registered trials
- How much does stem cell therapy for Stroke Recovery cost? (2026)
- Stroke Recovery stem cell therapy — your questions answered (2026)
- Stroke Recovery: cell-therapy evidence by therapy class
- MSC vs HSCT for Stroke Recovery: what the registries show